0001209191-12-018870.txt : 20120319 0001209191-12-018870.hdr.sgml : 20120319 20120319104552 ACCESSION NUMBER: 0001209191-12-018870 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120316 FILED AS OF DATE: 20120319 DATE AS OF CHANGE: 20120319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LUNDAHL SCOTT L CENTRAL INDEX KEY: 0001205850 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31533 FILM NUMBER: 12699504 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DUSA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000879993 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223103129 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25 UPTON DRIVE CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 9786577500 MAIL ADDRESS: STREET 1: 25 UPTON DRIVE CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: DEPRENYL USA INC / NJ DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2012-03-16 0 0000879993 DUSA PHARMACEUTICALS INC DUSA 0001205850 LUNDAHL SCOTT L C/O DUSA PHARMACEUTICALS, INC. 25 UPTON DRIVE WILMINGTON MA 01887 0 1 0 0 VP, Regulatory Affairs & IP Common Stock 2012-03-16 4 M 0 17500 1.60 A 228586 D Common Stock 2012-03-16 4 S 0 7976 5.75 D 220610 D Common Stock 2012-03-16 4 S 0 1900 5.76 D 218710 D Common Stock 2012-03-16 4 S 0 5224 5.80 D 213486 D Common Stock 2012-03-16 4 S 0 800 5.81 D 212686 D Common Stock 2012-03-16 4 S 0 1600 5.84 D 211086 D Non-Qualified Stock Option 1.60 2012-03-16 4 M 0 17500 0.00 D 2007-03-13 2013-03-13 common stock 17500 0 D Includes Stock Awards which vest at the rate of one-quarter of the total grant on each of the first, second, third and fourth anniversaries of the date of the grant. /s/ Nanette W. Mantell, Attorney-In-Fact for Scott L. Lundahl 2012-03-19